PDC Stock Overview Provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Pediatrix Medical Group, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Pediatrix Medical Group Historical stock prices Current Share Price US$13.70 52 Week High US$14.90 52 Week Low US$6.10 Beta 1.58 1 Month Change 9.60% 3 Month Change -0.72% 1 Year Change 58.38% 3 Year Change -34.76% 5 Year Change -39.91% Change since IPO 4.78%
Recent News & Updates
Pediatrix Medical Group, Inc. Announces CEO Changes Jan 13
Chair recently sold €401k worth of stock Nov 16 Pediatrix Medical Group, Inc. Provides Goodwill and Long-Lived Asset Impairments Guidance for the Year Ending December 31, 2024
Pediatrix Medical Group, Inc. to Report Q3, 2024 Results on Nov 01, 2024 Oct 16
Executive VP & CFO recently sold €461k worth of stock Aug 14
New minor risk - Shareholder dilution Aug 07 See more updates
Pediatrix Medical Group, Inc. Announces CEO Changes Jan 13
Chair recently sold €401k worth of stock Nov 16 Pediatrix Medical Group, Inc. Provides Goodwill and Long-Lived Asset Impairments Guidance for the Year Ending December 31, 2024
Pediatrix Medical Group, Inc. to Report Q3, 2024 Results on Nov 01, 2024 Oct 16
Executive VP & CFO recently sold €461k worth of stock Aug 14
New minor risk - Shareholder dilution Aug 07
New minor risk - Share price stability Jul 27
Pediatrix Medical Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024 Jul 18
First quarter 2024 earnings released: EPS: US$0.048 (vs US$0.17 in 1Q 2023) May 07
Pediatrix Medical Group, Inc. to Report Q1, 2024 Results on May 07, 2024 Apr 23
Pediatrix Medical Group, Inc., Annual General Meeting, May 09, 2024 Mar 29
Full year 2023 earnings released: US$0.73 loss per share (vs US$0.75 profit in FY 2022) Feb 22
Pediatrix Medical Group, Inc. to Report Q4, 2023 Results on Feb 20, 2024 Feb 08
Investor sentiment deteriorates as stock falls 17% Nov 10
New major risk - Revenue and earnings growth Nov 03
Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.35 in 3Q 2022) Nov 03
Pediatrix Medical Group, Inc. to Report Q3, 2023 Results on Nov 02, 2023 Oct 21
Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.36 in 2Q 2022) Aug 03
CEO & Director recently sold €172k worth of stock Jun 18
Independent Director recently sold €238k worth of stock May 23
Pediatrix Medical Group, Inc. Appoints Sylvia Young as an Independent Director, Effective May 12, 2023 May 06
First quarter 2023 earnings released: EPS: US$0.17 (vs US$0.24 loss in 1Q 2022) May 03
Full year 2022 earnings released: EPS: US$750 (vs US$1.27 in FY 2021) Feb 18 Pediatrix Medical Group, Inc. Announces Executive Changes
CEO & Director recently sold €334k worth of stock Nov 25
High number of new and inexperienced directors Nov 16
Executive VP & Chief Operating Officer recently sold €368k worth of stock Nov 11
Third quarter 2022 earnings released: EPS: US$0.35 (vs US$0.37 in 3Q 2021) Nov 04
Pediatrix Medical Group, Inc. to Report Q3, 2022 Results on Nov 03, 2022 Oct 22
Pediatrix Medical Group, Inc. Announces Executive Changes Sep 24
Second quarter 2022 earnings released: EPS: US$0.36 (vs US$0.36 in 2Q 2021) Aug 05
Pediatrix Medical Group, Inc. to Report Q2, 2022 Results on Aug 04, 2022 Jul 14
Mednax Announces Leadership Appointments May 19
First quarter 2022 earnings released: US$0.24 loss per share (vs US$0.063 profit in 1Q 2021) Apr 29
High number of new directors Apr 27
MEDNAX, Inc. to Report Q1, 2022 Results on Apr 28, 2022 Apr 20
MEDNAX, Inc., Annual General Meeting, May 12, 2022 Apr 02
MEDNAX, Inc. Announces Resignation of Roger Mack Hinson as President of Pediatrix and Obstetrix Medical Group, Effective as of June 1, 2022 Feb 26
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 18
MEDNAX, Inc. Provides Earnings Guidance for the Year 2022 Feb 18
MEDNAX, Inc. to Report Q4, 2021 Results on Feb 17, 2022 Feb 08
MEDNAX, Inc. (NYSE:MD) acquired Night Lite Pediatrics. Feb 05
Senior VP & Chief Accounting Officer recently sold €215k worth of stock Oct 31
Third quarter 2021 earnings released: EPS US$0.37 (vs US$0.032 loss in 3Q 2020) Oct 30
Senior VP & Chief Accounting Officer recently sold €268k worth of stock Sep 05
Second quarter 2021 earnings released: EPS US$0.36 (vs US$0.085 in 2Q 2020) Aug 08
New 90-day high: €23.60 Mar 16
Full year 2020 earnings released: US$0.12 loss per share (vs US$13.77 loss in FY 2019) Feb 20
Revenue misses expectations Feb 20
MEDNAX, Inc. to Report Q4, 2020 Results on Feb 18, 2021 Feb 06
New 90-day high: €20.00 Jan 23
Federman & Sherwood Files First Data Breach Case Against MedNax, Inc. and Pediatrix Medical Group Jan 20
New 90-day high: €19.60 Dec 23
New 90-day high: €17.20 Dec 04
New 90-day high: €16.60 Nov 16
Revenue misses expectations Nov 07
Third quarter 2020 earnings released: US$0.032 loss per share Nov 07
New 90-day low: €12.80 Oct 16
New 90-day low: €14.10 Sep 24
Executive VP recently sold €352k worth of stock Sep 18
New 90-day high - €17.30 Aug 07
MEDNAX, Inc. to Report Q2, 2020 Results on Jul 30, 2020 Jul 18
MEDNAX, Inc. Announces Executive Change Jul 17
MEDNAX, Inc.(NYSE:MD) dropped from Russell 1000 Dynamic Index Jul 04
MEDNAX, Inc.(NYSE:MD) dropped from Russell 1000 Index Jul 02 Shareholder Returns PDC DE Healthcare DE Market 7D 0% 1.5% 1.9% 1Y 58.4% 39.2% 15.1%
See full shareholder returns
Return vs Market: PDC exceeded the German Market which returned 15.1% over the past year.
Price Volatility Is PDC's price volatile compared to industry and market? PDC volatility PDC Average Weekly Movement 7.5% Healthcare Industry Average Movement 4.8% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: PDC's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PDC's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors.
Show more Pediatrix Medical Group, Inc. Fundamentals Summary How do Pediatrix Medical Group's earnings and revenue compare to its market cap? PDC fundamental statistics Market cap €1.14b Earnings (TTM ) -€244.88m Revenue (TTM ) €1.94b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) PDC income statement (TTM ) Revenue US$2.01b Cost of Revenue US$1.58b Gross Profit US$426.99m Other Expenses US$680.82m Earnings -US$253.84m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -3.00 Gross Margin 21.27% Net Profit Margin -12.65% Debt/Equity Ratio 85.6%
How did PDC perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/02 12:15 End of Day Share Price 2025/01/31 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Pediatrix Medical Group, Inc. is covered by 31 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution David Toung Argus Research Company Matthew Gillmor Baird James Kumpel BB&T Capital Markets
Show 28 more analysts 
